Camarillo I G, Thordarson G, Ilkbahar Y N, Talamantes F
Department of Biology, University of California, Santa Cruz 95064, USA.
Endocrinology. 1998 Aug;139(8):3585-9. doi: 10.1210/endo.139.8.6160.
A RIA for mouse GH receptor (mGHR) was developed. A synthetic peptide corresponding to the carboxyl-terminal 14 amino acids of the mGHR (GHR-2 peptide) was used as the antigen for antiserum production. The synthetic peptide was also used as the standard and radioligand in the RIA. The ability of the antiserum to recognize the mGHR was demonstrated by quantitating receptor concentrations in liver and mammary gland from virgin and 15-day-pregnant mice. Serial dilutions of these samples yielded displacement curves parallel to the synthetic peptide. No significant cross-reactivity was seen with serum from virgin or 15-day-pregnant mice, mGH, recombinant mGH-binding protein (mGHBP), a synthetic peptide identical to the hydrophilic tail of mGHBP, or a 14-amino acid synthetic peptide corresponding to amino acids 338-351 of mGHR (GHR-1 peptide). The concentration range of the mGHR RIA was 0.5-200 nM, and the intra- and interassay coefficients of variation were 6.5% and 6.1%, respectively. The concentration of liver GHR increased significantly during pregnancy compared with that in virgin mice, from 0.246 +/- 0.045 pmol/mg protein (mean +/- SEM; n = 5) in the virgin animals to 1.015 +/- 0.159 pmol/mg protein (n = 5) in pregnant mice. In contrast, the mGHR concentration in the mammary gland decreased significantly during pregnancy from 0.606 +/- 0.201 pmol/mg protein (mean +/- SEM; n = 5) to 0.299 +/- 0.027 pmol/mg protein (n = 5). Comparison of the total number of binding sites in livers from virgin and pregnant mice using the GH RRA and the combined results of the mGHR and mGHBP RIAs showed that the two methods gave almost identical results for livers from virgin animals, or 0.363 +/- 0.063 pmol/mg protein (mean +/- SEM; n = 3) and 0.371 +/- 0.008 pmol/mg protein (n = 3) for the GH RRA and the mGHR plus mGHBP RIAs, respectively. However, in livers from pregnant animals, the combined results from the mGHR and mGHBP RIAs were approximately 1.8 times higher than those obtained by the GH RRA, or 6.732 +/- 0.612 pmol/mg protein (mean +/- SEM; n = 3) and 3.693 +/- 0.67 pmol/mg protein (n = 3) for the mGHR plus the mGHBP RIAs and the GH RRA, respectively. The increase in the total GH binding capacity in livers from pregnant mice compared with those from virgin animals was largely due to an increase in the GHBP content. The increase in GHR was only 2.4-fold, or from 0.153 +/- 0.01 pmol/mg protein (mean +/- SEM; n = 3) in virgin mice to 0.364 +/- 0.03 pmol/mg protein (n = 3) in the 15-day-pregnant mice, whereas GHBP increased almost 30-fold during pregnancy, or from 0.218 +/- 0.003 pmol/mg protein (mean +/- SEM; n = 3) in virgin animals to 6.369 +/- 0.607 pmol/mg protein (n = 3) in pregnant mice.
建立了一种用于检测小鼠生长激素受体(mGHR)的放射免疫分析方法(RIA)。一种对应于mGHR羧基末端14个氨基酸的合成肽(GHR - 2肽)被用作抗原以产生抗血清。该合成肽也用作RIA中的标准品和放射性配体。通过定量未孕和妊娠15天小鼠肝脏和乳腺中的受体浓度,证明了抗血清识别mGHR的能力。这些样品的系列稀释产生了与合成肽平行的置换曲线。未观察到与未孕或妊娠15天小鼠的血清、mGH、重组mGH结合蛋白(mGHBP)、与mGHBP亲水尾相同的合成肽或对应于mGHR氨基酸338 - 351的14氨基酸合成肽(GHR - 1肽)有显著交叉反应。mGHR RIA的浓度范围为0.5 - 200 nM,批内和批间变异系数分别为6.5%和6.1%。与未孕小鼠相比,妊娠期间肝脏GHR浓度显著增加,未孕动物肝脏中为0.246±0.045 pmol/mg蛋白(平均值±标准误;n = 5),妊娠小鼠中为1.015±0.159 pmol/mg蛋白(n = 5)。相反,妊娠期间乳腺中mGHR浓度显著降低,从0.606±0.201 pmol/mg蛋白(平均值±标准误;n = 5)降至0.299±0.027 pmol/mg蛋白(n = 5)。使用生长激素受体放射受体分析(GH RRA)以及mGHR和mGHBP RIA的综合结果比较未孕和妊娠小鼠肝脏中的结合位点数,结果表明对于未孕动物肝脏,两种方法给出的结果几乎相同,GH RRA为0.363±0.063 pmol/mg蛋白(平均值±标准误;n = 3),mGHR加mGHBP RIA为0.371±0.008 pmol/mg蛋白(n = 3)。然而,对于妊娠动物的肝脏,mGHR和mGHBP RIA的综合结果比GH RRA获得的结果高约1.8倍,mGHR加mGHBP RIA为6.732±0.612 pmol/mg蛋白(平均值±标准误;n = 3),GH RRA为3.693±0.67 pmol/mg蛋白(n = 3)。与未孕动物相比,妊娠小鼠肝脏中总生长激素结合能力的增加主要是由于GHBP含量的增加。GHR的增加仅为2.4倍,从未孕小鼠中的0.153±0.01 pmol/mg蛋白(平均值±标准误;n = 3)增加到妊娠15天小鼠中的0.364±0.03 pmol/mg蛋白(n = 3),而GHBP在妊娠期间增加了近30倍,从未孕动物中的0.218±0.003 pmol/mg蛋白(平均值±标准误;n = 3)增加到妊娠小鼠中的6.369±0.607 pmol/mg蛋白(n = 3)。